The Emerging Role of Extracellular Vesicles in Endocrine Resistant Breast Cancer

SIMPLE SUMMARY: Two-thirds of breast cancer patients present an estrogen receptor–positive tumor at diagnosis, and the main treatment options for these patients are endocrine therapies such as aromatase inhibitors, selective modulators of estrogen receptor activity or selective estrogen receptor dow...

Descripción completa

Detalles Bibliográficos
Autores principales: La Camera, Giusi, Gelsomino, Luca, Caruso, Amanda, Panza, Salvatore, Barone, Ines, Bonofiglio, Daniela, Andò, Sebastiano, Giordano, Cinzia, Catalano, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962645/
https://www.ncbi.nlm.nih.gov/pubmed/33800302
http://dx.doi.org/10.3390/cancers13051160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962645/
https://www.ncbi.nlm.nih.gov/pubmed/33800302
http://dx.doi.org/10.3390/cancers13051160

Ejemplares similares